Medicus Pharma Ltd.
MDCX
$2.17
-$0.05-2.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.04% | -124.32% | 23.13% | 18.54% | -112.77% |
| Total Depreciation and Amortization | -- | -- | -398.10% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 233.80% | -27.96% | 1,994.44% | -98.71% | 939.46% |
| Change in Net Operating Assets | -75.24% | 193.02% | -665.23% | -189.67% | -65.33% |
| Cash from Operations | -38.77% | -20.62% | -6.49% | -10.49% | -135.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | 200.00% | -- | -- |
| Issuance of Common Stock | 84.54% | 84.62% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,209.60% | -161.58% | -- | -- | -- |
| Cash from Financing | 196.77% | 76.87% | 6,172.29% | -100.33% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,226.50% | 84.07% | 63.20% | -139.45% | 768.35% |